Tobias Weber

High treatment efficacy by dual targeting of Burkitt’s lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab

Michaela A. E. Arndt, D. Jäger, U. Haberkorn, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Preclinical evaluation of a diabody-based (177)Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model.

Michaela A. E. Arndt, D. Jäger, U. Haberkorn, 2016, Cancer letters.

A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells

Michaela A. E. Arndt, D. Jäger, W. Mier, 2015, Journal of immunology research.

A fusogenic dengue virus-derived peptide enhances antitumor efficacy of an antibody-ribonuclease fusion protein targeting the EGF receptor.

D. Jäger, R. Kontermann, G. Dyckhoff, 2014, Protein engineering, design & selection : PEDS.

Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential

D. Jäger, R. Kontermann, G. Dyckhoff, 2013, mAbs.

An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo.

Michaela A. E. Arndt, C. Körber, N. Halama, 2015, Cancer letters.